Bioengineering and Medical Devices Unit

Develops and optimizes bioengineering platforms to produce new commercial products focused on the early detection and prevention of metabolic disorders associated with obesity.

What does this unit do?

1. Bioengineering of processes to identify and produce bioactives.
2. Development of medical devices for early detection and monitoring.
3. Engineering of delivery systems and detection of molecules.
4. Generation of clinical interventions that positively impact society.

Products and services developed by the unit

Selection of novel biomolecules associated with metabolic diseases.
Medical devices (based on new technologies, user-friendly and accessible) for the early detection and monitoring of metabolic diseases.
Real-time detection sensors of biomarkers associated with metabolic diseases.
Improvement of the performance of existing platforms for the early detection and monitoring of metabolic diseases.
Prevention and treatment strategies for metabolic diseases and their complications.
Strategies for the prediction and monitoring of risk of metabolic diseases.

Meet the researchers

Marco Antonio Rito Palomares
Unit leader. Full Research Professor

Development of early detection technologies, drug delivery systems and strategies based on aqueous two-phase systems.
Get to know his work

Jorge Alejandro Benavides Lozano
Associate Research Professor

Bioengineering, Bioprocesses, Bioproduct formulation, Bioactive discovery and characterization, Synthetic biology.
Get to know his work

Karla Patricia Mayolo Deloisa
Research Professor

Specialist in nanoparticle formulation, protein modification and bioprocesses.
Get to know her work

Omar Lozano García
Assistant Research Professor

Design of advanced materials for drug delivery systems and probes, preclinical studies, nanosafety, nano-bio-interactions.
Get to know his work

Alexandro José Martagón Rosado
Assistant Research Professor

Physician-researcher with translational focus in the study of metabolic diseases, such as obesity, type 2 diabetes and dyslipidemias.
Get to know his work